Ellington Management Group’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-2,700
Closed -$395K 870
2019
Q1
$395K Buy
+2,700
New +$391K 0.07% 288
2016
Q4
Sell
-2,600
Closed -$599K 899
2016
Q3
$599K Buy
+2,600
New +$635K 0.17% 217
2015
Q2
Sell
-1,900
Closed -$565K 975
2015
Q1
$565K Buy
+1,900
New +$542K 0.12% 249
2014
Q3
Sell
-1,200
Closed -$268K 522
2014
Q2
$268K Hold
1,200
0.13% 266
2014
Q1
$247K Buy
+1,200
New +$238K 0.07% 453

Other funds holding AGN

Ellington Management Group's AGN Position: Q2 2019 in Review

Ellington Management Group sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 2,700 shares — an estimated $395K sold.

Ellington Management Group first reported a position in AGN in Q1 2014 and held it in 5 quarters. The position peaked at $599K in Q3 2016. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Ellington Management Group reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Ellington Management Group sold 2,700 Allergan plc shares in Q2 2019, an estimated $395K.
  • Ellington Management Group first reported a position in Allergan plc in Q1 2014 and held it in 5 quarters.
  • Ellington Management Group's Allergan plc position peaked at $599K in Q3 2016.
  • 971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Ellington Management Group's 13F filing for Q2 2019, filed 14 Aug 2019.